e439 sion protocols will significantly decrease blood-use rates. in this sense, over-ordering of preoperative blood is common practice in elective surgery, often without a proper analysis of the real needs of surgical procedures. 2 Preoperative identification of risk factors for transfusion has been used to create preoperative blood-ordering protocols based on the following calculations: the crossmatched:transfusion blood ratio, the number of patients transfused compared with those cross-matched (transfusion probability), and the number of units transfused relative to the number of cross-matched units (transfusion index). the values justifying blood ordering were crossmatched:transfusion blood ratio ≤2, transfusion probability >50%, and transfusion index ≥0.5 3 our group previously published a retrospective study of 457 patients scheduled for elective colonic surgery where we found that transfusion rates were far from their optimal values (cross-matched:transfusion blood ratio = 5.34, transfusion probability = 16.2, and transfusion index = 0.18). Predictors of perioperative transfusion were previous diagnosis of chronic obstructive pulmonary disease (oR = 3.7 (95% Ci, 1.3-10.7)), chronic cardiac disease (oR = 5.7 (95% Ci, 1.7-19.5)), surgical time >120 minutes (oR = 10.7 (95% Ci, 4.8-24.1)), and preoperative plasma hemoglobin <10 g/dl (oR = 309.8 (95% Ci, 52.7-985.2)).
Preoperative identification of risk factors for transfusion has been used to create preoperative blood-ordering protocols based on the following calculations: the crossmatched:transfusion blood ratio, the number of patients transfused compared with those cross-matched (transfusion probability), and the number of units transfused relative to the number of cross-matched units (transfusion index). the values justifying blood ordering were crossmatched:transfusion blood ratio ≤2, transfusion probability >50%, and transfusion index ≥0.5 3 our group previously published a retrospective study of 457 patients scheduled for elective colonic surgery where we found that transfusion rates were far from their optimal values (cross-matched:transfusion blood ratio = 5.34, transfusion probability = 16.2, and transfusion index = 0.18). Predictors of perioperative transfusion were previous diagnosis of chronic obstructive pulmonary disease (oR = 3.7 (95% Ci, 1.3-10.7)), chronic cardiac disease (oR = 5.7 (95% Ci, 1.7-19.5)), surgical time >120 minutes (oR = 10.7 (95% Ci, 4.8-24.1)), and preoperative plasma hemoglobin <10 g/dl (oR = 309.8 (95% Ci, 52.7-985.2)). 4 Based on these data we have continued with a prospective study to analyze the results of our preoperative blood-ordering protocol in the first 3 years of its implementation, which only included cross-matched blood for patients with risk factors for transfusion. a total of 268 consecutive patients undergoing elective colon surgery in 2013-2015 have been included in the analysis. all of the patients underwent elective colon surgery with plasma hemoglobin levels >10 g/dl. Considering the risk factors for transfusion, there were 94 total preoperative cross-matched red blood cell units, which were ordered in 47 patients (17.5%). of these, 24 patients (51.1%) actually had a transfusion, and a total of 54 red blood cell units were used. the transfusion ratios were crossmatched:transfusion blood ratio of 1.44, transfusion probability of 61.7%, and transfusion index of 0.69. a total of 221 patients (82.5%), without risk factors for transfusion, were not cross-matched preoperatively, and only 5 of them (2.3%) received a transfusion in the first 24 hours after surgery (a total of 11 red blood cell units). none of these 5 patients needed an emergency transfusion because of a serious surgical adverse event.
We have found that following a protocol has significantly adjusted the ordering of preoperative crossmatched blood to the actual need according to procedure in elective colonic surgery. this protocol is based on easily measured risk factors and is added evidence that the adoption of protocols can reduce the variation in blood ordering and blood transfusion rates. performed in case of recurrence, with associated delayed anastomotic complications. We completely agree with Dr Pai on the potential of anastomotic leakage in oncologic outcomes, because this was highlighted in a recent meta-analysis published by mirnezami et al. 2 however, none of the 110 patients included in our study received adjuvant bevacizumab. several points might explain this fact. 1) We do not advocate bevacizumab in patients with persisting leakage, because it might impair tract healing as highlighted by Dr Pai. 3 2) most importantly, in their meta-analysis, mirnezami et al 2 highlighted that patients with leakage are exposed to a higher risk of locoregional recurrences, which are most likely to be managed with radiochemotherapy and surgery, rather than metastatic recurrence, which might require systemic chemotherapy and especially bevacizumab.
finally, we completely agree with Dr Pai on his point highlighting that further research is mandatory on this topic to precisely define the optimal algorithm for these patients.
